Universe · entity
TCG Crossover Management, LLC
Institutional manager (13F) · CIK 1839948
13F holdings · as of 2026-03-31 · top 49 · reported portfolio $3.5B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | ABIVAX SA AMERICAN DEPOSITARY SHARES | $722M | 6,481,085 |
| 2 | CG ONCOLOGY INC | $248M | 3,670,206 |
| 3 | TANGO THERAPEUTICS INC | $220M | 10,531,071 |
| 4 | COGENT BIOSCIENCES INC | $190M | 4,946,894 |
| 5 | CENTESSA PHARMACEUTICALS PLC | $170M | 4,286,480 |
| 6 | DIANTHUS THERAPEUTICS INC | $141M | 1,676,624 |
| 7 | TYRA BIOSCIENCES INC | $124M | 3,248,980 |
| 8 | IMMUNOVANT INC | $111M | 4,457,988 |
| 9 | BIOCRYST PHARMACEUTICALS INC | $105M | 11,020,968 |
| 10 | MIRUM PHARMACEUTICALS INC | $98M | 1,062,049 |
| 11 | VOR BIOPHARMA INC | $96M | 5,673,078 |
| 12 | SPYRE THERAPEUTICS INC | $96M | 1,900,582 |
| 13 | AMYLYX PHARMACEUTICALS INC | $87M | 6,243,812 |
| 14 | DISC MEDICINE INC | $86M | 1,341,862 |
| 15 | DYNE THERAPEUTICS INC | $84M | 4,615,144 |
| 16 | MONTE ROSA THERAPEUTICS INC | $76M | 4,622,151 |
| 17 | SAVARA INC | $67M | 12,362,205 |
| 18 | REVOLUTION MEDICINES INC | $56M | 576,473 |
| 19 | KODIAK SCIENCES INC | $55M | 1,445,538 |
| 20 | LB PHARMACEUTICALS INC | $45M | 1,839,489 |
| 21 | SURROZEN INC | $43M | 1,473,101 |
| 22 | ADC THERAPEUTICS SA | $43M | 11,390,175 |
| 23 | RELAY THERAPEUTICS INC | $43M | 4,273,356 |
| 24 | FULCRUM THERAPEUTICS INC | $40M | 5,250,000 |
| 25 | BIOHAVEN LTD | $39M | 4,631,317 |
| 26 | CENTURY THERAPEUTICS INC | $39M | 17,754,430 |
| 27 | TECTONIC THERAPEUTIC INC | $37M | 1,204,891 |
| 28 | PERSPECTIVE THERAPEUTICS INC | $33M | 7,915,567 |
| 29 | XENCOR INC | $30M | 2,452,138 |
| 30 | ENTRADA THERAPEUTICS INC | $29M | 2,287,500 |
| 31 | ALX ONCOLOGY HOLDINGS INC | $26M | 13,011,849 |
| 32 | ARVINAS HOLDING CO LLC | $25M | 2,387,461 |
| 33 | JANUX THERAPEUTICS INC | $25M | 1,789,617 |
| 34 | AGOMAB THERAPEUTICS NV | $22M | 2,053,233 |
| 35 | ALECTOR INC | $22M | 10,000,000 |
| 36 | MBX BIOSCIENCES INC | $19M | 650,000 |
| 37 | SILENCE THERAPEUTICS PLC | $16M | 3,033,560 |
| 38 | LIQUIDIA TECHNOLOGIES INC | $15M | 403,048 |
| 39 | OCULAR THERAPEUTIX INC | $14M | 1,647,752 |
| 40 | AVALO THERAPEUTICS INC | $11M | 738,383 |
| 41 | UROGEN PHARMA LTD | $7M | 405,365 |
| 42 | MONOPAR THERAPEUTICS INC | $7M | 132,103 |
| 43 | CONTEXT THERAPEUTICS INC | $7M | 2,682,696 |
| 44 | STRUCTURE THERAPEUTICS INC | $7M | 140,411 |
| 45 | CULLINAN THERAPEUTICS INC | $6M | 406,786 |
| 46 | KORRO BIO INC | $5M | 416,301 |
| 47 | LEONABIO INC | $5M | 464,398 |
| 48 | UPSTREAM BIO INC | $2M | 181,063 |
| 49 | VISTAGEN THERAPEUTICS INC | $2M | 2,676,580 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.